61 related articles for article (PubMed ID: 21152693)
1. Quantification of tumour hypoxia. Functional histology and autoradiography.
Bussink J
Nuklearmedizin; 2010; 49 Suppl 1():S37-40. PubMed ID: 21152693
[TBL] [Abstract][Full Text] [Related]
2. Dose prescription and optimisation based on tumour hypoxia.
Toma-Daşu I; Daşu A; Brahme A
Acta Oncol; 2009; 48(8):1181-92. PubMed ID: 19863227
[TBL] [Abstract][Full Text] [Related]
3. PET and PET/CT studies of tumor tissue oxygenation.
Krause BJ; Beck R; Souvatzoglou M; Piert M
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):28-43. PubMed ID: 16557202
[TBL] [Abstract][Full Text] [Related]
4. The effects of hypoxia on the theoretical modelling of tumour control probability.
Daşu A; Toma-Daşu I; Karlsson M
Acta Oncol; 2005; 44(6):563-71. PubMed ID: 16165915
[TBL] [Abstract][Full Text] [Related]
5. Anatomical imaging for radiotherapy.
Evans PM
Phys Med Biol; 2008 Jun; 53(12):R151-91. PubMed ID: 18495981
[TBL] [Abstract][Full Text] [Related]
6. Oxygen-sensing in tumors.
Verma A
Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):366-78. PubMed ID: 16778564
[TBL] [Abstract][Full Text] [Related]
7. 18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors.
Troost EG; Bussink J; Hoffmann AL; Boerman OC; Oyen WJ; Kaanders JH
J Nucl Med; 2010 Jun; 51(6):866-74. PubMed ID: 20484426
[TBL] [Abstract][Full Text] [Related]
8. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland.
Stone HB; Brown JM; Phillips TL; Sutherland RM
Radiat Res; 1993 Dec; 136(3):422-34. PubMed ID: 8278585
[TBL] [Abstract][Full Text] [Related]
9. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
[TBL] [Abstract][Full Text] [Related]
10. [Angiogenesis and radiotherapy (vessels, anaemia, oxygen and radiosensitivity)].
Lartigau E
Bull Cancer; 2007 Jul; 94 Spec No():S197-202. PubMed ID: 17846005
[TBL] [Abstract][Full Text] [Related]
11. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D; Brown JM
Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
[TBL] [Abstract][Full Text] [Related]
12. Impact of hypoxia and the metabolic microenvironment on radiotherapy of solid tumors. Introduction of a multi-institutional research project.
Zips D; Adam M; Flentje M; Haase A; Molls M; Mueller-Klieser W; Petersen C; Philbrook C; Schmitt P; Thews O; Walenta S; Baumann M
Strahlenther Onkol; 2004 Oct; 180(10):609-15. PubMed ID: 15480508
[TBL] [Abstract][Full Text] [Related]
13. Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation.
Harting C; Peschke P; Borkenstein K; Karger CP
Phys Med Biol; 2007 Aug; 52(16):4775-89. PubMed ID: 17671335
[TBL] [Abstract][Full Text] [Related]
14. Construction of mutant TKGFP for real-time imaging of temporal dynamics of HIF-1 signal transduction activity mediated by hypoxia and reoxygenation in tumors in living mice.
Hsieh CH; Kuo JW; Lee YJ; Chang CW; Gelovani JG; Liu RS
J Nucl Med; 2009 Dec; 50(12):2049-57. PubMed ID: 19910419
[TBL] [Abstract][Full Text] [Related]
15. Advances in image-guided radiation therapy--the role of PET-CT.
Heron DE; Smith RP; Andrade RS
Med Dosim; 2006; 31(1):3-11. PubMed ID: 16551524
[TBL] [Abstract][Full Text] [Related]
16. Patterns of tumor oxygenation and their influence on the cellular hypoxic response and hypoxia-directed therapies.
Magagnin MG; Koritzinsky M; Wouters BG
Drug Resist Updat; 2006; 9(4-5):185-97. PubMed ID: 16926105
[TBL] [Abstract][Full Text] [Related]
17. Tumor biology-guided radiotherapy treatment planning: gross tumor volume versus functional tumor volume.
Guha C; Alfieri A; Blaufox MD; Kalnicki S
Semin Nucl Med; 2008 Mar; 38(2):105-13. PubMed ID: 18243845
[TBL] [Abstract][Full Text] [Related]
18. Challenges in integrating 18FDG PET-CT into radiotherapy planning of head and neck cancer.
Dandekar P; Partridge M; Kazi R; Nutting C; Harrington K; Newbold K
Indian J Cancer; 2010; 47(3):260-6. PubMed ID: 20587900
[TBL] [Abstract][Full Text] [Related]
19. Molecular PET/CT imaging-guided radiation therapy treatment planning.
Zaidi H; Vees H; Wissmeyer M
Acad Radiol; 2009 Sep; 16(9):1108-33. PubMed ID: 19427800
[TBL] [Abstract][Full Text] [Related]
20. The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts.
Harada H; Kizaka-Kondoh S; Itasaka S; Shibuya K; Morinibu A; Shinomiya K; Hiraoka M
Biochem Biophys Res Commun; 2007 Sep; 360(4):791-6. PubMed ID: 17624305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
